The Illumina-backed company has raised additional funding after becoming the first company to sequence multiple human genomes using portable technology.
Oxford Nanopore Technologies, a UK-based portable DNA and RNA sequencer developer backed by genomics company Illumina, raised £100m ($126m) yesterday from a consortium led by investment fund GT Healthcare.
The round included intellectual property-focused investment firm IP Group, investment fund Woodford Investment Management and undisclosed new and existing backers.
Founded in 2005 as a spinout of Oxford University, Oxford Nanopore has created a portable device called the Minion that provides real-time biological analysis at low cost.
The technology has applications…
